These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 24607494

  • 21. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
    Gousias K, Niehusmann P, Gielen G, Simon M, Boström J.
    J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
    [Abstract] [Full Text] [Related]

  • 22. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
    Shamsara J, Sharif S, Afsharnezhad S, Lotfi M, Raziee HR, Ghaffarzadegan K, Moradi A, Rahighi S, Behravan J.
    Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Diagnostic value of WT1 in neuroepithelial tumours.
    Schittenhelm J, Beschorner R, Simon P, Tabatabai G, Herrmann C, Schlaszus H, Capper D, Weller M, Meyermann R, Mittelbronn M.
    Neuropathol Appl Neurobiol; 2009 Feb; 35(1):69-81. PubMed ID: 18466223
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. IDH1 mutation of gliomas with long-term survival analysis.
    Myung JK, Cho HJ, Park CK, Kim SK, Phi JH, Park SH.
    Oncol Rep; 2012 Nov; 28(5):1639-44. PubMed ID: 22922798
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions.
    Roszkowski K, Furtak J, Zurawski B, Szylberg T, Lewandowska MA.
    Int J Mol Sci; 2016 Nov 10; 17(11):. PubMed ID: 27834917
    [Abstract] [Full Text] [Related]

  • 34. Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
    Li MY, Wang YY, Cai JQ, Zhang CB, Wang KY, Cheng W, Liu YW, Zhang W, Jiang T.
    PLoS One; 2015 Nov 10; 10(6):e0130872. PubMed ID: 26115094
    [Abstract] [Full Text] [Related]

  • 35. Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
    Ogura R, Tsukamoto Y, Natsumeda M, Isogawa M, Aoki H, Kobayashi T, Yoshida S, Okamoto K, Takahashi H, Fujii Y, Kakita A.
    Neuropathology; 2015 Aug 10; 35(4):324-35. PubMed ID: 25950388
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Single-copy gain of chromosome 1q is a negative prognostic marker in pediatric nonependymal, nonpilocytic gliomas.
    Miwa T, Hirose Y, Sasaki H, Ezaki T, Yoshida K, Kawase T.
    Neurosurgery; 2011 Jan 10; 68(1):206-12. PubMed ID: 21099717
    [Abstract] [Full Text] [Related]

  • 38. Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss.
    Li X, Wei J, Liu Y, Li P, Fan L, Wang Y, Li M, Zhao D, Yu Z, Ye J, Guo Y, Yan Q, Guo S, Wang Z.
    Sci Rep; 2017 Oct 12; 7(1):13038. PubMed ID: 29026176
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.